Page 10 - Gresham Technologies News Today

IN BRIEF: Gresham Technologies wins Clareti deal with financial firm | Financial News

6 January 2021 | 16:38pm StockMarketWire.com - A fall in sterling amid concern about the Covid situation in the UK, hopes for super-charged stimulus across the Atlantic and rising oil prices as OPEC announced output cuts helped lift the FTSE 100 3.5% to 6,841.86, its highest levels in more than 10 months. Expectations for a Democrat trifecta of control of the White House, Senate and House of Representatives is expected to lead to a more generous US stimulus package. US stocks were mixed with bi...

6 January 2021 | 08:30am StockMarketWire.com - Software and services Gresham Technologies said it expected to report a rise in annual adjusted earnings thanks to recurring revenue growth that beat market expectations. For the year ended 31 December 2020, adjusted EBITDA was expected to be least £4.4 million, an 7% increase on the prior year, while revenue fell 2% to £24.6 million. Clareti annualised recurring revenue was expected to rise 29% to £12.3 million supported by new business wins. ...

6 January 2021 | 12:00pm StockMarketWire.com - Hopes that a Democrat trifecta of control of the White House, Senate and House of Representatives will lead to a more generous US stimulus package was driving share prices higher on Wednesday. By midday the FTSE 100 was up 2.5% to 6,778.56, its highest level since February 2020, amid projections that Democrats could secure the balance of power in the Senate based on two run-off elections in Georgia. US futures were mixed with technology stocks und...

6 January 2021 | 09:00am StockMarketWire.com - The FTSE 100 made moderate gains this morning, continuing its strong start to 2021 as the UK undertakes its massive Covid-19 vaccine rollout. Markets also reacted to news that the Democrats were close to full control of the levers of government in the US after Senate run-off elections in the US. High-street bakery chain Greggs estimated annual losses of up to £15 million and forecast that profit would not return to pre-COVID levels until 2022 at ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost Wed, 23rd Dec 2020 19:50 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Polarean Imaging PLC - medical imaging products developer - Says US Food & Drug Administration approves companys new drug application. "FDA acceptance for the filing of Polareans NDA represents another important step forward for the Companys platform. If appro...